日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug-tolerant persister cells in head and neck squamous cell carcinoma: Molecular mechanisms and therapeutic opportunities

头颈部鳞状细胞癌中的耐药持续细胞:分子机制和治疗契机

Ling, Hang Huong; Huang, Huei-Yu; Huang, Chih-Ming; Yasir, Muhammad; Ko, Chun-Chen; Yadav, Vijesh Kumar; Kuo, Kuang-Tai; Yeh, Chi-Tai; Tsai, Jo-Ting

RHOJ-induced chemotherapy resistance through epithelial-mesenchymal transition in drug-tolerant persister cells of head and neck cancer.

RHOJ 通过上皮-间质转化诱导头颈癌耐药持久细胞产生化疗耐药性。

Ling Hang Huong, Huang Chih-Ming, Hsieh Ming-Shou, Yadav Vijesh Kumar, Fong Iat-Hang, Kuo Kuang-Tai, Yeh Chi-Tai, Tsai Jo-Ting

O-GlcNAcylation expression predicts a favorable prognosis and mitigates malignant phenotypes via MYCN suppression in neuroblastoma

O-GlcNAc糖基化表达预示着良好的预后,并通过抑制MYCN基因表达来减轻神经母细胞瘤的恶性表型。

Lin, Neng-Yu; Chang, Hsiu-Hao; Hsieh, Chia-Yeh; Chang, Hsiu-Ling; Ho, Wan-Ling; Liu, Yen-Lin; Wu, Pei-Yi; Yeh, Chi-Tai; Huang, Min-Chuan; Hsu, Wen-Ming

APOBEC3B/ASF1B-TGF-β signaling axis promotes epithelial-mesenchymal transition in HPV-positive oropharyngeal cancer

APOBEC3B/ASF1B-TGF-β信号轴促进HPV阳性口咽癌的上皮-间质转化

Hsieh, Ming-Shou; Sheen, Chih-Chi; Hsu, Tung-Nien; Yeh, Chi-Tai; Chang, Wei Jen; Wu, Yang-Che

Correction: Su et al. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Int. J. Mol. Sci. 2023, 24, 7706

更正:Su 等人,《NADPH 氧化酶亚基 CYBB 通过 Nrf2/SOD2 调控赋予间充质胶质母细胞瘤化疗和铁死亡抵抗力》,《国际分子科学杂志》,2023 年,24 卷,7706 页。

Su, I-Chang; Su, Yu-Kai; Setiawan, Syahru Agung; Yadav, Vijesh Kumar; Fong, Iat-Hang; Yeh, Chi-Tai; Lin, Chien-Min; Liu, Heng-Wei

Lipoprotein(a)/CD36 Interaction Drives IL-6/RhoA-GTP Signaling and miRNA Epigenetic Regulation in Coronary Artery Spasm.

脂蛋白(a)/CD36相互作用驱动冠状动脉痉挛中的IL-6/RhoA-GTP信号传导和miRNA表观遗传调控。

Lin Yen-Kuang, Hsieh Tsung-Han, Yeh Chi-Tai, Yadav Vijesh Kumar, Fong Iat-Hang, Kuo Kuang-Tai, Kounis Nicholas G, Hu Patrick, Hung Ming-Yow

Correction: Bamodu et al. 4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression. Cancers 2018, 10, 269

更正:Bamodu 等人,《4-乙酰基-Antroquinonol B 通过诱导 hsa-miR-324 重新表达抑制 SOD2 增强的癌症干细胞样表型和结直肠癌细胞的化疗耐药性》,Cancers 2018, 10, 269

Bamodu, Oluwaseun Adebayo; Yang, Ching-Kuo; Cheng, Wei-Hong; Tzeng, David T W; Kuo, Kuang-Tai; Huang, Chun-Chih; Deng, Li; Hsiao, Michael; Lee, Wei-Hwa; Yeh, Chi-Tai

Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cells

靶向FABP4/UCP2轴以克服肥胖驱动的结直肠癌中存在的耐药持续细胞的西妥昔单抗耐药性

Cheng, Yi-Chiao; Chen, Ming-Yao; Yadav, Vijesh Kumar; Pikatan, Narpati Wesa; Fong, Iat-Hang; Kuo, Kuang-Tai; Yeh, Chi-Tai; Tsai, Jo-Ting

Correction: Lee et al. Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma. Biomedicines 2023, 11, 2081

更正:Lee 等人,《肿瘤相关巨噬细胞通过上调 CXCL6/CXCR2 影响肝细胞癌的肿瘤微环境和放射抗性》,Biomedicines 2023, 11, 2081

Lee, Hsin-Lun; Tsai, Yi-Chieh; Pikatan, Narpati Wesa; Yeh, Chi-Tai; Yadav, Vijesh Kumar; Chen, Ming-Yao; Tsai, Jo-Ting

Correction: MED10 drives the oncogenicity and refractory phenotype of bladder urothelial carcinoma through the upregulation of hsa-miR-590

更正:MED10 通过上调 hsa-miR-590 驱动膀胱尿路上皮癌的致癌性和难治性表型

Wu, Chia-Chang; Wang, Yuan-Hung; Hu, Su-Wei; Wu, Wen-Ling; Yeh, Chi-Tai; Bamodu, Oluwaseun Adebayo